Showing results (511-520 of 1,957) with videos related to
Sort By:
Pageof 196
Journal of Psychoactive Drugs|November 10, 2024
The Risk Assessment Before Dose Tapering Among Methadone Maintenance Treatment Participants: Derivation and Validation of a NomogramChijie Wang, Qian Lu, Boyu Li, et al.Journal of Psychoactive Drugs|November 11, 2024
Efficacy of Screening and Brief Intervention for Alcohol Misuse in Opioid Agonist Maintenance Treatment: A Randomized Clinical TrialSurabhi Gupta, Renjith R Pillai, Abhishek GhoshJournal of Psychoactive Drugs|November 4, 2024
Review and Call for Improved Cannabis Measurement and the Potential for Leveraging Cannabis Seed-To-Sale SystemsMeme Wang-Schweig, Sara Zimmer, Ari Kirshenbaum, et al.Journal of Psychoactive Drugs|November 5, 2024
Safety and Efficacy of Ashwagandha Root Extract on Cognition, Energy and Mood Problems in Adults: Prospective, Randomized, Placebo-Controlled StudySanjiv Kale, Adrian Lopresti, Ravleen Suri, et al.Journal of Psychoactive Drugs|November 6, 2024
Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of UseOmer A Syed, Rotem Petranker, Emily C Fewster, et al.Journal of Psychoactive Drugs|November 4, 2024
Does the Perception of Risk Associated with Psychedelics Use Differ in Physicians According to Their Belief of Effectiveness?A Bezo, B Roméo, Y Le Strat, et al.Journal of Psychoactive Drugs|October 8, 2025
Examining Volunteer Bias in Psychedelic ResearchSamantha G Gomez, Fiona Low, Mitch EarleywineJournal of Psychoactive Drugs|October 14, 2025
Tianeptine Products: Public Health Threat or Niche Substance use?Kirsten E Smith, Katherine Hill, Cecilia L Bergeria, et al.Journal of Psychoactive Drugs|October 10, 2025
Questions and Concerns About MDMA-Assisted Therapy (MDMA-AT) in Veterans with PTSD SymptomsMitch Earleywine, Caitlin Holley, Henry MacConnel, et al.Journal of Psychoactive Drugs|December 28, 2020
Pregabalin Misuse: Motives, Pattern, and Knowledge about Its Risks among Patients in Methadone Maintenance TreatmentEinat Peles, Anat Sason, Shaul Schreiber, et al.Pageof 196